Covered Stents - Global Strategic Business Report

The global market for Covered Stents was estimated at US$1.1 Billion in 2024 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Covered Stents market.

Global Covered Stents Market - Key Trends & Drivers Summarized

Why Are Covered Stents Gaining Widespread Adoption? Examining the Surge in Cardiovascular Interventions

The global covered stents market has witnessed significant growth due to the rising prevalence of cardiovascular diseases, peripheral artery disease (PAD), and aneurysms. With an increasing number of patients requiring minimally invasive vascular interventions, covered stents have emerged as a critical medical device, offering superior protection against restenosis and vessel rupture. The growing aging population, which is more susceptible to arterial blockages and aneurysms, has further fueled market demand. Additionally, advancements in stent technology, including drug-eluting and bioresorbable covered stents, have enhanced treatment outcomes, making these devices a preferred choice among interventional cardiologists. The shift from open surgeries to catheter-based interventions has driven market expansion, as covered stents provide a less invasive alternative for complex vascular procedures. Rising awareness regarding early diagnosis and treatment of arterial diseases, coupled with an increase in healthcare expenditures, has also played a pivotal role in the market’s growth. Government initiatives promoting cardiovascular health, along with increased screening programs, have further accelerated the adoption of covered stents.

What Are the Leading Types of Covered Stents? Analyzing Market Segmentation by Material & Application

The covered stents market is categorized based on material composition, design, and application, each catering to specific medical requirements. PTFE (polytetrafluoroethylene) and ePTFE-covered stents are among the most widely used due to their biocompatibility, flexibility, and ability to minimize restenosis. Another dominant category is polyurethane-covered stents, known for their durability and ability to resist thrombus formation. In terms of applications, covered stents are extensively used in cardiovascular procedures, particularly in treating aortic aneurysms and coronary artery disease. Peripheral vascular applications, including the treatment of carotid and femoral arteries, have also witnessed increased adoption. Additionally, covered stents play a vital role in endoscopic interventions, particularly for managing bile duct obstructions and gastrointestinal tract diseases. The development of self-expanding and balloon-expandable covered stents has further diversified treatment options, allowing physicians to select the most appropriate device based on patient-specific vascular conditions. The rising adoption of hybrid stent designs, which combine metal scaffolding with bioresorbable polymer coatings, has also contributed to market growth.

How Is Innovation Driving the Future of Covered Stents? The Role of Bioengineering & Smart Stent Technologies

The covered stents market is rapidly evolving, driven by advancements in biomaterial science, bioengineering, and smart medical technologies. The introduction of drug-eluting covered stents has significantly improved patient outcomes by reducing the risk of restenosis and thrombosis. Nanotechnology-based coatings, including anti-inflammatory and antimicrobial agents, have further enhanced stent performance, minimizing post-procedural complications. The emergence of biodegradable and bioresorbable stents represents a breakthrough in vascular treatment, as these stents gradually dissolve after fulfilling their therapeutic purpose, eliminating long-term complications. Additionally, AI-powered imaging and robotic-assisted catheterization techniques have improved precision in stent placement, reducing procedural risks. The integration of smart stents with embedded sensors capable of monitoring blood flow and detecting restenosis in real-time is another revolutionary advancement shaping the market. Personalized medicine approaches are also gaining traction, with 3D printing technology enabling patient-specific stent customization for enhanced vascular compatibility.

What’s Fueling the Growth of the Covered Stents Market? Key Market Drivers Explained

The growth in the covered stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and increasing adoption of minimally invasive procedures. The expansion of healthcare infrastructure in emerging economies has improved access to interventional cardiology treatments, further propelling market demand. Favorable reimbursement policies and government initiatives aimed at reducing the burden of cardiovascular diseases have also encouraged the adoption of covered stents. Additionally, the growing number of clinical trials focused on next-generation stent technologies has fueled innovation, leading to the development of safer and more effective devices. The increasing preference for outpatient procedures, driven by cost-effectiveness and faster recovery times, has further expanded the market. With continuous advancements in stent materials, digital health integration, and personalized vascular solutions, the global covered stents market is expected to witness sustained growth, offering improved patient outcomes and enhanced healthcare efficiency.

Report Scope

The report analyzes the Covered Stents market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Product (Vascular Stent, Non-vascular Stent); End-Use (Hospitals End-Use, Ambulatory Care Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Vascular Stent segment, which is expected to reach US$991.7 Million by 2030 with a CAGR of a 3.9%. The Non-vascular Stent segment is also set to grow at 1.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $310.9 Million in 2024, and China, forecasted to grow at an impressive 6.3% CAGR to reach $275.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Covered Stents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Covered Stents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Covered Stents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Laboratories, Alvimedica, AndraTec GmbH, Artivion, Inc., B. Braun Interventional Systems, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 36 Featured):

• Abbott Laboratories
• Alvimedica
• AndraTec GmbH
• Artivion, Inc.
• B. Braun Interventional Systems, Inc.
• BD Interventional
• Bentley InnoMed GmbH
• Biosensors International Group, Ltd.
• Biotronik AG
• Boston Scientific Corporation
• Cook Medical
• Cordis (a Cardinal Health company)
• Getinge AB
• Gore Medical (W. L. Gore & Associates)
• iVascular S.L.U.
• Lepu Medical Technology Co., Ltd.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Terumo Corporation

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry